SEC Form 4 · accession 0001179022-15-000079
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gilbert S Omenn
Director
Period of report
Mar 12, 2015
Accepted (ET)
Jul 8, 2015 · 4:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 12, 2015 | A | 11,112 | $0.00 | A | 40,121 | D | |
| Common Stock | Apr 7, 2015 | A | 1,506 | $0.00 | A | 41,627 | D | |
| Common Stock | Apr 8, 2015 | A | 25,934 | $0.00 | A | 67,561 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $5.06 | Apr 8, 2015 | D | 28,323 | D | — | Sep 23, 2024 | Common Stock | 28,323 | 0 | D |
Explanation of responses
- F125,071 options vested upon grant and 3,252 options vested ratably through February 11, 2015.
- F2The option was canceled by mutual agreement of the reporting person and Galectin Therapeutics, Inc. The reporting person received 25,934 shares of restricted common stock, reported in Table 1 of this Form 4, as consideration for the cancellation of options granted on September 23, 2014.